Á
Ángel Brea
Publications - 40
Citations - 1289
Ángel Brea is an academic researcher. The author has contributed to research in topics: Familial hypercholesterolemia & Liver cancer. The author has an hindex of 12, co-authored 39 publications receiving 1099 citations.
Papers
More filters
Journal ArticleDOI
Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study.
TL;DR: Patients with NAFLD show a cluster of risk factors of the metabolic syndrome and advanced carotid atherosclerosis, and its detection on abdominal ultrasound should alert to the existence of an increased cardiovascular risk.
Journal ArticleDOI
Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Leopoldo Pérez de Isla,Rodrigo Alonso,Nelva Mata,Cristina Fernández-Pérez,Ovidio Muñiz,José Luis Díaz-Díaz,Adriana Saltijeral,Francisco Fuentes-Jiménez,Raimundo de Andrés,Daniel Zambón,Mar Piedecausa,José María Cepeda,Marta Mauri,Jesús Galiana,Ángel Brea,Juan F. Sánchez Muñoz-Torrero,Teresa Padró,Rosa Argüeso,Jose Pablo Miramontes-Gonzalez,Lina Badimon,Raul D. Santos,Gerald F. Watts,Pedro Mata +22 more
TL;DR: Although risk factors for atherosclerotic cardiovascular disease (ASCVD) in familial hypercholesterolemia (FH) have been described, models for predicting incident ASCVD have not been developed.
Journal ArticleDOI
Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up
Leopoldo Pérez de Isla,Rodrigo Alonso,Gerald F. Watts,Nelva Mata,Adriana Saltijeral Cerezo,Ovidio Muñiz,Francisco Fuentes,José Luis Díaz-Díaz,Raimundo de Andrés,Daniel Zambón,Patricia Rubio-Marin,Miguel Ángel Barba-Romero,Pedro Saenz,Juan F. Sánchez Muñoz-Torrero,Ceferino Martínez-Faedo,Jose Pablo Miramontes-Gonzalez,Lina Badimon,Pedro Mata,Safeheart Investigators,Rocío Aguado,Fátima Almagro,Francisco Arrieta,Miguel Ángel Barba,Ángel Brea,José María Cepeda,Gonzalo Díaz,José Luis Díaz,Jesús Galiana,Juan Antonio Garrido,Luis Irigoyen,Laura Manjón,Alberto García Martín,Mar Piedecausa,Marta Mauri,Pablo Miramontes,Francisca Pereyra,Leire Pérez,Xavier Pintó,Pedro Pujante,Enrique Ruiz,Juan F. Sánchez,Jose I. Vidal,Rosa Argüeso +42 more
TL;DR: Type of LDL-receptor mutation, use of ezetimibe, coexistent diabetes, and ASCVD status can bear significantly on the likelihood of attaining low-density lipoprotein cholesterol (LDL-C) treatment goals in FH patients enrolled in a large national registry.
Journal ArticleDOI
Non-alcoholic fatty liver disease and cardiovascular risk
Ángel Brea,José Puzo +1 more
TL;DR: An update to the etiopathogenesis of NAFLD, its influence on cardiovascular disease, and the treatment options is provided.
Journal ArticleDOI
Epidemiología de la enfermedad vascular cerebral en España
TL;DR: La hipertension arterial fue el factor de riesgo cardiovascular (FRCV) mas prevalente, tanto en los ictus isquemicos como los hemorragicos, seguida of the dislipidemia y the diabetes mellitus.